Toshimitsu Isobe

Iwaki Seiyaku Co., Ltd. manufactures and sells pharmaceuticals. Its products include over-the-counter drugs, veterinary drugs, pharmaceutical intermediates, food additives, cosmetic raw materials, dyes, and pigment intermediates. The company was founded on January 28, 1931 and is headquartered in Tokyo, Japan.

Iwaki Seiyaku Co., Ltd. manufactures and sells pharmaceuticals. Its products include over-the-counter drugs, veterinary drugs, pharmaceutical intermediates, food additives, cosmetic raw materials, dyes, and pigment intermediates. The company was founded on January 28, 1931 and is headquartered in Tokyo, Japan.

Iwaki Seiyaku Co., Ltd. manufactures and sells pharmaceuticals. Its products include over-the-counter drugs, veterinary drugs, pharmaceutical intermediates, food additives, cosmetic raw materials, dyes, and pigment intermediates. The company was founded on January 28, 1931 and is headquartered in Tokyo, Japan.

Iwaki Seiyaku Co., Ltd. manufactures and sells pharmaceuticals. Its products include over-the-counter drugs, veterinary drugs, pharmaceutical intermediates, food additives, cosmetic raw materials, dyes, and pigment intermediates. The company was founded on January 28, 1931 and is headquartered in Tokyo, Japan.

Spera Pharma, Inc., engages in the pharmaceuticals contract research & development and manufacturing business. It offers chemical process research & development, supply chain optimization, formulation development, packaging, technology transfer, regulatory filing of clinical studies and commercial application. The company was founded on April 20, 2017 and is headquartered in Osaka, Japan.

Spera Pharma, Inc., engages in the pharmaceuticals contract research & development and manufacturing business. It offers chemical process research & development, supply chain optimization, formulation development, packaging, technology transfer, regulatory filing of clinical studies and commercial application. The company was founded on April 20, 2017 and is headquartered in Osaka, Japan.

Spera Pharma, Inc., engages in the pharmaceuticals contract research & development and manufacturing business. It offers chemical process research & development, supply chain optimization, formulation development, packaging, technology transfer, regulatory filing of clinical studies and commercial application. The company was founded on April 20, 2017 and is headquartered in Osaka, Japan.